The onco-bariatric paradigm: a tri-phasic metabolic obesity framework for synergizing glucagon-like peptide-1 receptor agonists and metabolic bariatric surgery
Obesity is a chronic, progressive neuroendocrine disease that warrants a shift toward an “onco-bariatric” treatment paradigm. This study introduces the tri-phasic metabolic obesity (TPMO) framework, which integrates glucagon-like peptide-1 receptor agonists (GLP-1 RAs) with metabolic bariatric surge...
Spremljeno u:
| Glavni autori: | , , , , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Kosin University College of Medicine
2026-03-01
|
| Serija: | Kosin Medical Journal |
| Teme: | |
| Online pristup: | http://www.kosinmedj.org/upload/pdf/kmj-26-154.pdf |
| Oznake: |
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|
